Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY

Company number 05557934

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
04 May 2020 SH01 Statement of capital following an allotment of shares on 30 April 2020
  • GBP 24,254,335.5
01 May 2020 AP01 Appointment of Mr Douglas Malcolm Hurt as a director on 1 May 2020
02 Jan 2020 SH01 Statement of capital following an allotment of shares on 31 December 2019
  • GBP 24,231,917
04 Dec 2019 CH01 Director's details changed for Ali Mohammed Al Husry on 29 November 2005
02 Dec 2019 SH01 Statement of capital following an allotment of shares on 30 November 2019
  • GBP 24,231,901
05 Nov 2019 SH01 Statement of capital following an allotment of shares on 31 October 2019
  • GBP 24,231,189.8
07 Oct 2019 CS01 Confirmation statement made on 9 September 2019 with no updates
01 Oct 2019 SH01 Statement of capital following an allotment of shares on 30 September 2019
  • GBP 24,229,688.4
02 Sep 2019 SH01 Statement of capital following an allotment of shares on 31 August 2019
  • GBP 24,227,915
01 Aug 2019 SH01 Statement of capital following an allotment of shares on 31 July 2019
  • GBP 24,227,848.6
02 Jul 2019 SH01 Statement of capital following an allotment of shares on 30 June 2019
  • GBP 24,226,532.7
21 Jun 2019 AA Group of companies' accounts made up to 31 December 2018
05 Jun 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES09 ‐ Resolution of authority to purchase a number of shares
  • RES13 ‐ Re-agm may be called on not less than 14 clear days notice 17/05/2019
  • RES10 ‐ Resolution of allotment of securities
03 Jun 2019 SH01 Statement of capital following an allotment of shares on 31 May 2019
  • GBP 24,224,149.5
03 Jun 2019 AP01 Appointment of Ms Cynthia Louise Schwalm as a director on 1 June 2019
01 May 2019 SH01 Statement of capital following an allotment of shares on 30 April 2019
  • GBP 24,195,378
01 Apr 2019 SH01 Statement of capital following an allotment of shares on 31 March 2019
  • GBP 24,162,988
01 Mar 2019 SH01 Statement of capital following an allotment of shares on 28 February 2019
  • GBP 24,146,773.7
04 Feb 2019 RP04CS01 Second filing of Confirmation Statement dated 04/09/2018
01 Feb 2019 SH01 Statement of capital following an allotment of shares on 31 January 2019
  • GBP 24,145,832
03 Dec 2018 SH01 Statement of capital following an allotment of shares on 30 November 2018
  • GBP 24,145,539.4
01 Nov 2018 SH01 Statement of capital following an allotment of shares on 31 October 2018
  • GBP 24,144,504.3
03 Oct 2018 SH01 Statement of capital following an allotment of shares on 30 September 2018
  • GBP 24,144,171.7
04 Sep 2018 CS01 Confirmation statement made on 4 September 2018 with no updates
  • ANNOTATION Clarification a second filed CS01 (Trading status of shares and exemption from keeping a register of people with significant control (psc)) was registered on 04/02/2019.
03 Sep 2018 SH01 Statement of capital following an allotment of shares on 31 August 2018
  • GBP 24,142,316